Research graph
References from B-cell-targeted therapy for systemic lupus erythematosus-associated warm autoimmune haemolytic anaemia: a real-world comparative cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort
10.1002/art.24020 · 2008 · External reference
Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients
10.1177/0961203316676379 · 2017 · External reference
Impact and management of warm autoimmune haemolytic anaemia associated with systemic lupus erythematosus
10.1016/j.autrev.2025.103858 · 2025 · External reference
Warm autoimmune hemolytic anemia and the best treatment strategies
10.1182/hematology.2022000405 · 2022 · External reference
Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival
10.1177/0961203319877245 · 2019 · External reference
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: a systematic review and meta-analysis
10.1016/j.autrev.2021.102913 · 2022 · External reference
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
10.1136/ard-2023-224762 · 2024 · External reference
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus
10.1002/acr.25690 · 2026 · External reference
B-Cell-Targeted Therapy for Systemic Lupus Erythematosus
10.2165/00063030-200822040-00003 · 2008 · External reference
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: a multicenter retrospective cohort study of 71 adults
10.1002/ajh.24999 · 2018 · External reference
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
10.1111/bjh.12541 · 2013 · External reference
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
10.1016/s0140-6736(10)61354-2 · 2011 · External reference
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
10.1002/art.30613 · 2011 · External reference
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
10.1056/nejmoa2001180 · 2020 · External reference
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
10.1136/ard-2023-224854 · 2024 · External reference
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
10.1056/nejmoa2414719 · 2025 · External reference
Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study
10.1007/s10157-024-02501-x · 2024 · External reference
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
10.1002/art.34473 · 2012 · External reference
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
10.1002/art.40930 · 2019 · External reference
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials
10.1136/lupus-2025-001830 · 2026 · External reference
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: data from a multiethnic Latin American cohort
10.1177/09612033231163745 · 2023 · External reference
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus
10.1016/s0002-9343(99)00413-1 · 2000 · External reference
Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting
10.1016/j.blre.2019.100648 · 2020 · External reference
Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia
10.1111/bjh.14654 · 2017 · External reference
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
10.1093/rheumatology/kex286 · 2018 · External reference
The diagnosis and management of primary autoimmune haemolytic anaemia
10.1111/bjh.14478 · 2017 · External reference
Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases
10.1191/0961203306lu2292oa · 2006 · External reference
